Once-weekly efsitora noninferior to degludec for type 2 diabetes
By
HealthDay News
Sep 13, 2024
Once-weekly efsitora was noninferior to once-daily degludec for a decrease in the mean glycated hemoglobin level.
SGLT2i use linked to lower risk for neurodegenerative disease in T2DM
By
HealthDay News
Sep 18, 2024
A reduced risk for Alzheimer’s disease, vascular dementia and Parkinson’s disease was seen with SGLT2i use in type 2 diabetes.
Low-dose triple-pill protocol lowers BP in Black Africans with hypertension
By
Haymarket Media
Sep 10, 2024
The mean home systolic blood pressure was lower with the triple-pill protocol versus the standard-care protocol at month 6.
FDA expands use of breast cancer drug Kisqali
By
HealthDay News
Sep 18, 2024
The medication already was approved for advanced disease.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Timing of blood pressure meds has no impact on outcomes
By
Haymarket Media
Sep 10, 2024
The findings were seen for both primary care patients with hypertension and nursing home residents.
Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
Adjunctive IV argatroban, eptifibatide do not cut disability after stroke
By
Haymarket Media
Sep 06, 2024
The findings were seen among patients with acute ischemic stroke who were treated with intravenous thrombolysis within three hours after symptom onset.
Time from drug approval to reimbursement longer in US than some European countries
By
Haymarket Media
Sep 03, 2024
France has highest reimbursement rate one month after approval, while U.S. and Germany had no drugs reimbursed at one month
Increasing thiazide dose linked to greater reduction in calcium
By
Haymarket Media
Aug 28, 2024
The cumulative incidence of symptomatic stone event decreased with the increasing calcium change after thiazide prescription.